Solvac SA, a public limited liability company traded on Euronext Brussels, holds 30.71% of company shares. Additional shareholders include Blackrock Inc. (3.40%) and Solvay Stock Option Management SPRL (2.72%).
CEO: Ilham Kadri
The company is publicly traded on Euronext Brussels under the ticker symbol SOLB.BE. It also has a secondary listing on Euronext Paris and its shares are traded over the counter (OTC) as a Level 1 sponsored American Depository Receipt (ADR) through Citibank.